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Editorial Comment
Potential Role of Serotonin in
Dynamic Coronary Stenosis*
ROBERTO BOLLI, MD, FACC
Houston, Texas
There is compelling evidence that the obstruction associated
with a coronary artery stenosis is often dynamic rather than
fixed . Pathologic studies (1) have shown that most (-70%)
coronary stenoses are eccentric and partially circumscribed
by normal arterial wall . Arteriographic studies ( ) have
demonstrated that most stenoses dilate after administration
of nitroglycerin and that epicardial coronary arteries can
constrict or dilate in response to a variety of vasoactive
stimuli. In certain eccentric lesions, a 10% circumferential
shortening of the normal wall may cause dramatic changes in
luminal caliber ( ) . Clinically, numerous observations sup-
port the concept of a variable obstruction . For example, the
threshold for exertional angina can change markedly at
different times of the day, and angina can be precipitated at
rest by emotional stress, cold or handgrip . The extreme
(although infrequent) example is that of patients with variant
angina, whose epicardial coronary arteries undergo spasm
resulting in total or subtotal luminal occlusion . However,
more subtle variations of coronary tone may play an impor-
tant role in determining the clinical manifestations of myo-
cardial ischemia in perhaps the majority of patients with
coronary artery disease ( ,3) .
Mechanisms of fluctuations in coronary vasomotor tone .
Despite the importance of these concepts, the mechanism or
mechanisms responsible for the fluctuations of vasomotor
tone in stenotic coronary arteries remain enigmatic . Our
ignorance regarding the modulation of stenosis resistance
stems in part from the lack of experimental studies . Thus far,
most experimental investigators (4-7) concerned with coro-
nary stenosis have focused on the role of platelet-mediated
thrombus formation . Accordingly, most studies have em-
ployed a rigid, fixed narrowing that precludes active vaso-
motion, so that changes in blood flow can be unequivocally
ascribed to formation or dissolution of platelet aggregates .
These preparations have provided important insights into the
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mechanisms of thrombus formation . However, the clinical
situation is likely to be more complex because both throm-
bosis and vasoconstriction (separately or in combination)
may play an important role in precipitating acute myocardial
ischemia . In contrast to thrombus formation, experimental
investigation of the role of active vasomotion in a stenotic
coronary artery has been lacking . Clearly, if the mechanisms
of such vasomotion are to be elucidated, it is essential that
experimental models of compliant stenosis (with or without
associated thrombus formation) be developed .
The present study . In this issue of the Journal, Ichikawa
et al. (8) describe the effects of serotonin on coronary blood
flow in the presence of a coronary stenosis in open chest
dogs, and demonstrate that such effects differ depending on
whether the stenosis is compliant or fixed. The study pro-
vides two important new findings : 1) serotonin can produce
marked constriction of compliant coronary stenoses ; and )
this effect is mediated by non-S -serotonergic receptors .
Previous investigations (9,10) had shown that serotonin
constricts normal epicardial coronary arteries in vivo, but
the effects of this amine on a stenotic coronary artery were
not examined .
Limitations . As for any other animal study, the findings
must be extrapolated to the clinical setting with great cau-
tion. Because anesthesia and surgical trauma may impor-
tantly modify the responsiveness of coronary arteries to
vasoactive agents, the findings need to be confirmed in
awake animal preparations . Further, the authors' conclusion
that the detrimental effects of serotonin on compliant coro-
nary stenoses were not due to removal of the endothelium
may be incorrect . Although histologic analysis failed to
reveal gross endothelial disruption, the surgical manipula-
tions associated with the production of a stenosis are likely
to result in various degrees of endothelial damage or dys-
function, or both. Because the effect of serotonin on epicar-
dial coronary arteries appears to be the net result of direct
vasoconstriction and endothelium-mediated vasodilation
(11,1 ), it is possible that the increase in stenosis resistance
effected by serotonin was due to loss of endothelial function .
This, however, would not limit the clinical relevance of the
study because endothelial dysfunction is a common feature
of coronary artery disease (11,13,14) .
Clinical implications . The demonstration that serotonin
can markedly increase stenosis resistance has potential
clinical implications . There are several reasons to postulate
a significant role of this amine in dynamic coronary stenoses .
First, activation of serotonergic receptors by ergonovine
causes marked constriction of human epicardial coronary
arteries ( ) . Second, serotonin is present in abundant quan-
tities in platelets and is released during platelet activation .
Coronary artery disease is frequently associated with endo-
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thelial injury, which promotes platelet adhesion and aggre-
gation (6,11) . Such aggregation need not be massive ; it may
be subtle and self-limited, but nevertheless sufficient to
release locally active vasoconstrictive substances . In vitro
studies (11,1 ) have shown that aggregating platelets cause
contraction of arteries denuded of endothelial cells, which is
inhibited by serotonin antagonists . Increased shear forces
could also cause platelet activation . Third, endothelial dys-
function augments the serotonin-induced constriction of
epicardial coronary arteries in vivo (9) . In patients with
coronary artery disease, endothelial dysfunction appears to
occur both in stenotic sites (14) and in angiographically
normal coronary segments (13) . In experimental animals,
atherosclerosis greatly potentiates the vasoconstrictive ef-
fects of serotonin on epicardial coronary arteries (15), at
least in part because of the loss of endothelial integrity
associated with the atherosclerotic process . On the basis of
these considerations, it is reasonable to speculate that re-
lease of serotonin by activated platelets in the coronary
vasculature may cause constriction of stenotic coronary
arteries and thereby exacerbate the functional consequences
of such lesions .
One important observation of the study by Ichikawa et al .
(8) was that the detrimental effects of serotonin were not
prevented by the S -serotonergic antagonist, ketanserin .
This may help explain why clinical trials of ketanserin in
patients with Prinzmetal's angina (16) have yielded negative
results . On the other hand, S -serotonergic receptors appear
to mediate platelet aggregation and thrombosis in stenosed
coronary arteries (7) . Therefore, serotonin may participate
in the pathogenesis of acute myocardial ischemia by two
distinct mechanisms : 1) by promoting platelet aggregation
and thrombus formation by way of S -serotonergic mecha-
nisms, and ) by producing vasoconstriction by way of
non-S -serotonergic mechanisms . Depending on the type of
atherosclerotic lesion, one or the other of these mechanisms,
or both, may be operative .
The problem of modulation of vasomotor tone in compli-
ant coronary stenoses is undoubtedly more complex than the
simple release of serotonin by platelets. Nevertheless, the
study by Ichikawa et al. (8) represents a first step toward
elucidation of this issue and underscores the importance of
developing experimental models of dynamic coronary steno-
sis. For over a decade, the major emphasis of experimental
studies has been placed on the mechanisms of thrombus
formation in rigid coronary stenoses, and much has been
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learned from these endeavors . It is time to expand our
analysis and to initiate a similarly extensive investigation of
the mechanisms of active vasomotion in compliant coronary
stenoses .
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